Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > October 2015

« Previous month Next month »

Malaria protein conjugate could deliver anti-cancer drugs, researcher

30-Oct-2015 - A protein in malaria could be used to deliver anti-cancer drugs to many types of tumours.

Hanson, Shimadzu combine technologies to create an automated testing system

30-Oct-2015 - Hanson Research and Shimadzu have teamed up to combine their respective technologies into an automated online pharmaceutical testing system.

News focus

Women less likely to be prescribed post-heart attack drugs, researchers find

29-Oct-2015 - Younger women are less likely than younger men to be prescribed or fill their medication after a heart attack, new research shows.  

Bioprocess International

Pharma manufacturers using smart glasses for virtual POV

29-Oct-2015 - Big pharma is adopting Google Glass-type tech to remotely advise and monitor manufacturing operators, says the company licensing the handsfree tech.

Graphene could strip polluting medicines from wastewater

29-Oct-2015 - Pollution caused by pharmaceuticals in wastewater is a major challenge facing the industry, but researchers in Greece may have come up with a solution.

Self-guide nanomotor delivers, according to Dutch study

29-Oct-2015 - Researchers have taken a step closer to nanomotor-based drug delivery by creating a tiny motor to follow a chemical path towards target cells. 

Engineered banana protein shows potential as potent antiviral

28-Oct-2015 - A team of researchers has modified a lectin protein found in bananas to diminish its inflammatory properties, potentially setting it on the path to use as an antiviral.

Irish researchers generate crystal structure for a PEGylated protein

28-Oct-2015 - Irish scientists have completed the most comprehensive structural study yet of a PEGylated protein, giving greater insight into how such molecules improve injectable therapies.

Explosion-hit GSK plant loses GMP certificate

26-Oct-2015 - A GlaxoSmithKline plant in China that was hit by an explosion in the summer has had its Good Manufacturing Practice (GMP) certificate revoked by the UK medicines regulator.

Russia's clinical trial approvals 'on the increase'

26-Oct-2015 - The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction...

Immune cell binding nanoparticle could lead to new sepsis treatment

26-Oct-2015 - A nanoparticle that binds to immune cells in the body has been shown to tune down inflammation and offer a potential first-of-a-kind treatment for sepsis.  

Pfizer to hire 130 in Ireland

23-Oct-2015 - Pfizer has announced an extra 90 production jobs at Dublin’s Grange Castle biomanufacturing site, adding to the 40 hires it plans for its API facilities in Cork, Ireland.

News in brief

MHRA seizes $1.5m worth of unlicensed ED drugs

22-Oct-2015 - Around 500,000 doses of unlicensed erectile dysfunction (ED) drugs have been seized by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

AstraZeneca opens $224m Russian plant for local production

22-Oct-2015 - AstraZeneca has opened a $224m manufacturing site in Russia it says is the largest foreign pharma investment in the country.

CPhI Worldwide 2015

Rush to acquire ex-pharma sites means survival of the biggest for CMOs

22-Oct-2015 - As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say...

Biogen axing 11% of workforce in plan to save $250m annually

22-Oct-2015 - Biogen will cut around 530 US jobs as part of a restructuring plan it hopes will save $250m (€221m) in operating costs annually.

Pharmerging markets will be a $500bn 'game changer,' says Reva

21-Oct-2015 - ‘Pharmerging markets’ have extended beyond Brazil, Russia, India and China (BRIC) and will be worth $500bn by 2020, according to Reva Pharma.

CPhI Worldwide 2015

After the M&A bubble bursts: the four types of pharma firm to survive

21-Oct-2015 - An advisor to the pharma industry on M&A says the current boom in pharma valuations will not last, and R&D cost pressures will reshape firms of the future....

Sanofi actions hiring freeze on back of poor Afrezza performance, ex-sales rep claims

21-Oct-2015 - Sanofi has reportedly issued a hiring freeze across its commercial team for its inhaled insulin product, Afrezza.

News in brief

Medline recalls mislabelled paracetamol

20-Oct-2015 - Medline Industries has recalled a lot of acetaminophen (paracetamol) tablets after they were wrongly labelled with a lesser dose.

Compounder refuses to halt production despite FDA alert

20-Oct-2015 - The US FDA has issued an alert warning the public not to take drugs marked as sterile by compounding firm Qualgen.

Pay-as-you-go or unlimited access? EMD ups its risk assessment service

20-Oct-2015 - EMD Millipore will offer drugmakers two-years of unlimited access to its suite of raw materials dossiers for 20,000€ as part of its enhanced portfolio offering.

Hovione to refurbish ex-generics plant for oral and inhalable formulation site

20-Oct-2015 - Hovione will spend $10m refurbishing a plant acquired from a Portuguese generics company to create an oral and inhalation formulation site.


Allergan lays off 117

19-Oct-2015 -

FDA demands product quality information in CRL for Shire's dry eye candidate

19-Oct-2015 - Problems with manufacturing have left Shire with a Complete Response Letter for its dry eye disease small-molecule integrin inhibitor lifitegrast.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...